Espinoza Octavio bought LGND
June 30, 2026 · Form 4 insider transaction
Espinoza Octavio bought 17 shares of Ligand Pharmaceuticals Incorporated at $160.71 per share, a transaction worth $2.7K. The trade was recorded as j and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
17
Price
$160.71
Total value
$2.7K
InsiderEspinoza Octavio
Role—
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJune 30, 2026
Filing dateJuly 6, 2026
Shares owned after27,696
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired under the Ligand Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).